On behalf of Monsanto, which it carries as a US subsidiary, Bayer is pressing ahead with plans floated earlier to ask the US Supreme Court to review one of the three US...
In a deal potentially worth $2 billion, German drugs and agriculture company Bayer is acquiring Vividion Therapeutics, a San Diego-based US biotech. The California...
New wide-sweeping restrictions on the use of glyphosate, active ingredient in herbicides such as the Monsanto-developed Roundup and the subject of thousands of lawsuits...
Two EU authorities, the European Food Safety Agency (EFSA) and the European Chemicals Agency (ECHA), are poised to begin reviewing a draft assessment of the safety of...
Bayer has announced plans to acquire Noria Therapeutics and PSMA Therapeutics, thereby obtaining exclusive rights to a differentiated alpha radionuclide investigational...
Disappointed by San Francisco district judge Vince Chhabria’s decision to dismiss its proposed $2 billion plan to settle future claims that Monsanto’s flagship herbicide...
A US federal appeals court has upheld a $25 million jury award for the plaintiff in one of three major court battles Bayer has fought and lost over claims linking...
A Mexican court has reversed a ruling that favored Bayer in a legal challenge brought by the German pharmaceuticals and agrochemicals group against Mexico’s plan to ban...
